References
- Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. Plos Med. 2008;5:e45.
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
- Fried EI. The 52 symptoms of major depression. J Affect Disord. 2017;208:191–197.
- Cai N, Bigdeli TB, Kretzschmar W, et al. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature. 2015;523:588–591.
- Fried EI, Kievit RA. The volumes of subcortical regions in depressed and healthy individuals are strikingly similar: a reinterpretation of the results by Schmaal et al. Mol Psychiatry. 2016;21:724–725.
- Kupfer DJ, Kraemer HC Field trial results guide DSM recommendations. Huffington Post. (2013). [cited 2017 Mar1]. Available from: http://www.huffingtonpost.com/david-j-kupfer-md/dsm-5_b_2083092.html
- Insel TR Transforming diagnosis. National Institute of Mental Health. 2013. [cited 2017 Mar 1] Available from: http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml
- Fried EI. Problematic assumptions have slowed down depression research: why symptoms, not syndromes are the way forward. Front Psychol. 2015;6:1–11.
- Parker G. Beyond major depression. Psychol Med. 2005;35(4):467–474.
- Santor DA, Gregus M, Welch A. Eight decades of measurement in depression. Measurement. 2006;4:135–155.
- Fried EI, Nesse RM. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord. 2015;172:96–102.
- Fried EI, van Borkulo CD, Epskamp S, et al. Measuring depression over time or not? Lack of unidimensionality and longitudinal measurement invariance in four common rating scales of depression. Psychol Assess. 2016;28:1354–1367.
- Fried EI, Nesse RM. Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential. BMC Med. 2015;13:1–11.
- Jokela M, Virtanen M, Batty GD. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016;73:1–6.
- Hieronymus F, Emilsson JF, Nilsson S, et al. Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry. 2016;21:523–530.
- Chekroud AM, Gueorguieva R, Krumholz HM, et al. Reevaluating the efficacy and predictability of antidepressant treatments: a symptom clustering approach. JAMA Psychiatry. 2017;6511:1-9.
- Le Noury J, Nardo JM, Healy D, et al. Restoring study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. The BMJ. 2015;101006:1-16.
- Fried EI, van Borkulo CD, Cramer AOJ, et al. Mental disorders as networks of problems: a review of recent insights. Soc Psychiatry Psychiatr Epidemiol. 2016;1:1–32.
- Borsboom D. A network theory of mental disorders. World Psychiatry. 2017;16:5–13.
- Bos FM, Schoevers RA, Aan Het Rot M. Experience sampling and ecological momentary assessment studies in psychopharmacology: a systematic review. Eur Neuropsychopharmacol. 2015;25:1853–1864.
- Schuurman NK, Ferrer E, de Boer-Sonnenschein M, et al. How to compare cross-lagged associations in a multilevel autoregressive model. Psychol Methods. 2016;21:206–221.
- Chekroud AM, Zotti RJ, Shehzad Z, et al. Cross-trial prediction of treatment outcome in depression: a machine learning approach. The Lancet Psychiatry. 2016;366:1–8. [cited 2017 MAR 1]. Available at: http://linkinghub.elsevier.com/retrieve/pii/S221503661500471X
- Boschloo L, van Borkulo CD, Borsboom D, et al. A prospective study on how symptoms in a network predict the onset of depression. Psychother Psychosom. 2016;85(3):183–184.
- van Borkulo CD, Boschloo L, Borsboom D, et al. Association of symptom network structure with the course of longitudinal depression. JAMA Psychiatry. 2015;72:1219.
- Kramer I, Simons C, Hartmann JA, et al. A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry. 2014;13:68–77.
- Wichers M, Groot PC, Psychosystems, et al. Critical slowing down as a personalized early warning signal for depression. Psychother Psychosom. 2016;85:114–116.
- National Institute of Mental Health. Breaking ground, breaking through: the strategic plan for mood disorders research (NIH Publication No. 03–5121). Washington, DC: National Institutes of Health. 2003.